NASDAQ:RNAZ | Cash Flow Statement | Transcode Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$6.75M$23,937.00
2026-03-31-$17.79M$23,936.00-$4.98M
2025-12-31-$13.44M$44,780.00-$8.14M$23.12M
2025-09-30-$4.86M$4,781.00
2025-06-30-$4.28M$13,443.00
2025-03-31-$12.09M$13,443.00-$3.1M$8.85M
2024-12-31-$5.92M$10,346.00-$3.15M$500.00-$500.00$7.08M
2024-09-30-$2.32M$16,031.00
2024-06-30-$5.19M$32,354.00
2024-03-31-$3.33M$32,164.00-$3.94M$3,836.00-$3,836.00$6.09M
2023-12-31-$4.09M$31,655.00-$5.66M$0.00$0.00$978,153.00
2023-09-30-$5.3M$31,218.00
2023-06-30-$4.34M$30,970.00
2023-03-31-$4.82M$29,640.00-$4.51M$12,896.00-$12,896.00$1.18M
2022-12-31-$5.13M$29,505.00-$4.02M$28,215.00-$28,215.00$225,817.00
2022-09-30-$4.29M$24,802.00
2022-06-30-$4.67M$22,698.00
2022-03-31-$3.47M$21,601.00-$3.95M$30,657.00-$30,657.00$5,989.00
2021-12-31-$2.8M$28,988.00-$1.6M$85,728.00-$82,728.00$9,485.00
2021-09-30-$2.33M
2021-06-30$2.77M
2021-03-31-$4.49M$1,254.00-$522,153.00$75,301.00-$75,301.00-$131,600.00
2020-12-31-$801,531.00-$255,491.00-$12,429.00
2020-09-30-$1.37M
2020-06-30-$127,198.00
2020-03-31-$41,260.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$34.66M$76,446.00-$19.52M$6,660.00-$4,436.00$31.52M
2024-12-31-$16.75M$90,894.00-$13.34M$21,761.00-$21,761.00$16.4M
2023-12-31-$18.55M$123,483.00-$18.07M$35,609.00-$35,609.00$15.91M
2022-12-31-$17.56M$98,606.00-$15.76M$100,919.00-$100,919.00$5,989.00
2021-12-31-$6.84M$42,470.00-$5.27M$254,820.00-$251,820.00$25.52M
2020-12-31-$2.34M$0.00-$492,971.00$1.12M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.